FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Allele: Dmel\β-SpecSCA5.UAS
Open Close
General Information
Symbol
Dmel\β-SpecSCA5.UAS
Species
D. melanogaster
Name
FlyBase ID
FBal0337883
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Also Known As
UAS-βspecSCA5
Key Links
Genomic Maps

Transgenic product class
Nature of the Allele
Transgenic product class
Progenitor genotype
Carried in construct
Cytology
Description

UAS regulatory sequences drive expression of a mutant form of β-Spec which carries the amino acid replacement L246P (this mutation is equivalent to the spinocerebellar ataxia type 5 disease-associated L253P variant of the human SPTBN2 ortholog).

Allele components
Component
Use(s)
Encoded product / tool
Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Nucleotide change:

T17661920C

Amino acid change:

L246P | beta-Spec-PA; L246P | beta-Spec-PB; L246P | beta-Spec-PC

Comment:

Analogous L253P mutation in human SPTBN2 implicated in spinocerebellar ataxia 5; mutation carried on in vitro construct; site of nucleotide substitution in fly gene inferred by FlyBase curator based on reported amino acid change.

Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 1 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
This allele represents a human variant implicated in disease.
SPTBN2:p.Leu253Pro
Variants Synonym(s)
Associated human disease model(s)
External database links
Comments concerning this variant
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

The expression of β-SpecSCA5.Scer\UAS under the control of Scer\GAL4477 leads to third instar larval class IV da neurons showing a severe reduction in dendritic arborization size, with a complete loss of distal dendrites near segmental boundaries, with significant decreases in distal dendritic branch complexity, total dendritic branch length and number of dendritic branch points, as compared to controls; however, high-complexity terminal branching is still present near the ends of primary dendrites where complex terminal branching is observed in control neurons. These aforementioned defects are not observed at the early second instar larval stage.

β-Specem21 heterozygotes expressing β-SpecSCA5.Scer\UAS under the control of Scer\GAL4elav.PU are near lethal.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Phenotype Manifest In
Additional Comments
Genetic Interactions
Statement
Reference
Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments

The expression of β-SpecSCA5.Scer\UAS under the control of Scer\GAL4elav.PU fails to rescue the lethality of β-Specem21 hemizygotes.

Images (0)
Mutant
Wild-type
Stocks (0)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (2)
Reported As
Symbol Synonym
β-SpecSCA5.Scer\UAS
β-SpecSCA5.UAS
Name Synonyms
Secondary FlyBase IDs
    References (3)